Cardiotoxicity research hub

Cardiac Biomarkers in Patients Receiving Immune Checkpoint Inhibitors (PRIME-ICI)

This study looks at blood markers in people starting a type of cancer treatment called immune checkpoint inhibitors (ICIs). We want to understand why these markers, which can show heart strain, sometimes go up. It helps doctors know when a marker increase is due to the heart or something else, like an infection.